Our 2 hour critical appraisal and ASH review.  
SO many guest stars

2 HOUR ASH Presentation with AARON GOODMAN & MANNI & More

Is alcohol healthy for you? I break down everything you need to know about beer, wine, and spirits.

Alcohol - Is it healthy? Everything you need to know about Beer, Wine and Spirits

The entire healthcare system is broken, it's not just health insurance companies.

The ENTIRE healthcare system is broken, not just health insurance companies

I discuss Trump's big health care changes: NIH study sections, the MMWR gag order, the US withdrawal from WHO, and more!

Trump's Big Health Care Changes: NIH study sections, MMWR gag order, WHO withdrawal & more!

I discuss the CIA admitting that COVID was a lab leak; Fauci's pardon; NIH meetings; RFK Jr's Senate confirmation hearing; and more.

CIA says lab leak, Fauci's pardon, NIH's meetings, RFK Jr's hearing & more!

I discuss the recent reduction in indirect funds for NIH grants and lay out why the NIH is a broken funding system.

Why the NIH is a broken funding system

I'm talking about USAID and Elon's team of six engineers; the Bobby Kennedy Jr hearings, particularly concerning Samoa; MMR vaccines; DEI; and NIH funding complaints.

Elon's 6 Engineers/ Unelected/ RFK Jr/ MMR vaccines/ DEI/ USAID and NIH funding complaints

I discuss the intense media coverage of Trump and the recent decision to cap indirect costs of NIH grants at 15%.

Trump is breaking media brains / NIH cuts indirect payments and scientists freak out

I discuss RFK Jr.'s confirmation as the US Secretary of Health and Human Services; recent layoffs at the CDC and NIH; and some comments by Harold Varmus in criticism of Jay Bhattacharya. 

RFK Jr takes office/ CDC layoffs/ Varmus criticizes Jay's proposal for Academic Freedom

CABINET - trial - Cabozantinib for NET

In the first half of this episode, Dr. Sven Olson of OHSU joins us to help critique the recent NEJM paper, "Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura". In the second half, we interview Dr. Inmaculada Hernández of the University of Pittsburgh on her work on the economic principles behind runaway drug prices.

Caplacizumab: doi.org/10.1056/NEJMoa1806311

Back us on Patreon! www.patreon.com/plenarysession

February 2019

1.42 Caplacizumab for TTP with Dr. Sven Olson & Economics of Drug Pricing with Dr. Inma Hernández

Dr Prasad currently serves as the Director of the Center for Biologics Evaluation and Resesarch (CBER) at the US FDA. The audio on this platform were posted before my FDA employment and do not necessarily represent the views of the FDA or the United States. This site will be inactive during my federal service.

A podcast on medicine, oncology, & health policy. 
Host: Vinay Prasad, MD MPH from University of California San Francisco.
Tweet your feedback to @Plenary_Session or e-mail plenarysessionpodcast@gmail.com

1.42 Caplacizumab for TTP with Dr. Sven Olson & Economics of Drug Pricing with Dr. Inma Hernández

Plenary Session - inactive due to federal service

Related tracks